Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 17NETWORK 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3

Conditions

Multiple Myeloma 3

Interventions

daratumumab 3Dexamethasone 3Bortezomib 2sodium thiosulfate 1pomalidomide 1pembrolizumab 1etoposide phosphate 1darlin protein, Dictyostelium 1bosutinib 1Thalidomide 1Restraint, Physical 1Pemetrexed 1Mitoxantrone 1Lenalidomide 1Gemtuzumab 1Etoposide 1Daunorubicin 1Cytarabine 1Crizotinib 1Cisplatin 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Has announcements × Dexamethasone × Clear all
NCT03710603 2026-02-10

Perseus

European Myeloma Network B.V.

Phase 3 Active not recruiting
709 enrolled 17 charts 1 FDA
Plasma cell

Multiple Myeloma

NCT03180736 2025-12-19

EMN14

European Myeloma Network B.V.

Phase 3 Completed
304 enrolled 19 charts 1 FDA
Plasma cell

Multiple Myeloma

NCT02541383 2025-04-13

Cassiopeia

Intergroupe Francophone du Myelome

Phase 3 Completed
1,085 enrolled 22 charts 1 FDA
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡